ClinVar Genomic variation as it relates to human health
NM_000044.6(AR):c.1789G>A (p.Ala597Thr)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000044.6(AR):c.1789G>A (p.Ala597Thr)
Variation ID: 9813 Accession: VCV000009813.10
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: Xq12 X: 67686030 (GRCh38) [ NCBI UCSC ] X: 66905872 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Nov 24, 2024 Oct 8, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000044.6:c.1789G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000035.2:p.Ala597Thr missense NM_001011645.3:c.193G>A NP_001011645.1:p.Ala65Thr missense NM_001348061.1:c.1789G>A NP_001334990.1:p.Ala597Thr missense NM_001348063.1:c.1789G>A NP_001334992.1:p.Ala597Thr missense NM_001348064.1:c.1706G>A NP_001334993.1:p.Arg569His missense NC_000023.11:g.67686030G>A NC_000023.10:g.66905872G>A NG_009014.2:g.146999G>A LRG_1406:g.146999G>A LRG_1406t1:c.1789G>A LRG_1406p1:p.Ala597Thr P10275:p.Ala597Thr - Protein change
- A597T, A65T, R569H
- Other names
-
A771T
- Canonical SPDI
- NC_000023.11:67686029:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
AR | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
821 | 1035 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (3) |
criteria provided, single submitter
|
Oct 8, 2024 | RCV000010487.4 | |
Pathogenic (1) |
criteria provided, single submitter
|
Dec 17, 2023 | RCV000640478.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
Mar 15, 2018 | RCV001269612.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Mar 15, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics and Genomics, Karolinska University Hospital
Accession: SCV001449713.1
First in ClinVar: Dec 11, 2020 Last updated: Dec 11, 2020 |
Number of individuals with the variant: 2
|
|
Pathogenic
(Dec 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Kennedy disease
Androgen resistance syndrome
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000762070.4
First in ClinVar: May 28, 2018 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 597 of the AR protein (p.Ala597Thr). … (more)
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 597 of the AR protein (p.Ala597Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with AR-related conditions (PMID: 1598912, 26778393, 28261839). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 9813). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AR protein function. Experimental studies have shown that this missense change affects AR function (PMID: 1598912). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Oct 08, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Partial androgen insensitivity syndrome
(X-linked recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV005398349.1
First in ClinVar: Nov 24, 2024 Last updated: Nov 24, 2024 |
Comment:
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism … (more)
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with androgen insensitivity (MIM#300068), partial androgen insensitivity with or without breast cancer (MIM#312300), X-linked hypospadias 1 (MIM#300633), or spinal and bulbar muscular atrophy of Kennedy (MIM#313200). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to threonine. (I) 0253 - This variant is hemizygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v3: 0 heterozygotes, 0 homozygotes, 1 hemizygote). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated Zinc finger, C4 type DNA binding domain (DECIPHER, PMID: 29051026). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in more than ten individuals with partial androgen insensitivity syndrome (PAIS) (ClinVar, PMIDs: 10971094, 15963062, 1598912, 26778393, 28261839, 29785970, 29051026). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign (less)
|
|
Pathogenic
(Jun 01, 1992)
|
no assertion criteria provided
Method: literature only
|
ANDROGEN INSENSITIVITY, PARTIAL
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000030713.1
First in ClinVar: Apr 04, 2013 Last updated: Apr 04, 2013 |
Comment on evidence:
In 2 unrelated families, Klocker et al. (1992) demonstrated that the Reifenstein syndrome (312300) was due to a G-to-A transition at nucleotide 2314 of the … (more)
In 2 unrelated families, Klocker et al. (1992) demonstrated that the Reifenstein syndrome (312300) was due to a G-to-A transition at nucleotide 2314 of the AR gene, which changed the alanine codon (GCC) immediately after the first cysteine of the second zinc finger motif of the androgen receptor into a threonine codon (ACC). The 5 patients in the 2 families presented with perineoscrotal hypospadias and undescended testes. After puberty they showed small testes, no palpable prostate, micropenis, azoospermia, and gynecomastia. (less)
|
|
Pathogenic
(Nov 04, 2022)
|
no assertion criteria provided
Method: clinical testing
|
Partial androgen insensitivity syndrome
Affected status: yes
Allele origin:
germline
|
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein
Accession: SCV004808327.1
First in ClinVar: Apr 06, 2024 Last updated: Apr 06, 2024 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Phenotypic and molecular characteristics of androgen insensitivity syndrome patients. | Yuan SM | Asian journal of andrology | 2018 | PMID: 29785970 |
Mutational analysis of the androgen receptor (NR3C4) gene in patients with 46,XY DSD. | Ramos L | Gene | 2018 | PMID: 29051026 |
Clinical and molecular characteristics in 15 patients with androgen receptor gene mutations from South China. | Su L | Andrologia | 2017 | PMID: 28261839 |
Androgen insensitivity syndrome in a cohort of Sri Lankan children with 46, XY disorders of sex development (46, XY DSD). | de Silva KS | The Ceylon medical journal | 2015 | PMID: 26778393 |
Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. | Deeb A | Clinical endocrinology | 2005 | PMID: 15963062 |
Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor. | Lundberg Giwercman Y | Hormone research | 2000 | PMID: 10971094 |
Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. | Klocker H | American journal of human genetics | 1992 | PMID: 1598912 |
Text-mined citations for rs137852569 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.